Who Supplies Temozolomide? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Temozolomide exports, with 133+ registered manufacturers shipping to buyers across 90+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 36.9% (export value: $8.7M). Close behind, SUN PHARMACEUTICAL INDUSTRIES LTD (8.4%, $2.0M). RELIANCE LIFE SCIENCES PRIVATE LIMITED (4.8%, $1.1M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Temozolomide? Top Manufacturers & Their Buyers
Flow of Temozolomide from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Temozolomide Supplier Network — Key Market Intelligence
The Temozolomide export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 36.9% share, shipping $8.7M worth of product across 311 shipments. The second-largest exporter, SUN PHARMACEUTICAL INDUSTRIES LTD, contributes $2.0M (8.4%) to the overall market. Combined, the top two suppliers alone account for 45.3% of all Temozolomide exports, indicating a relatively concentrated supply base.
Across all 133 tracked manufacturers, the total Temozolomide export value stands at $23.5M from 1.3K shipments. The market average shipment value is $18.6K. The single largest buyer relationship in terms of trade value is YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN, receiving $3.1M worth of product.
The combined buyer network spans 19 named purchasing companies, including YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN, TARO PHARMACEUTICALS INC., M/S. SUN FARMACEUTICA DO BRAZIL LTD, SUN FARMACEUTICA DO BRASIL LTD, M S TARO PHARMACEUTI and 14 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Temozolomide exporter from India, with a market share of 36.9% and a total export value of $8.7M across 311 shipments. Their average shipment value of $27.9K is above the market average of $18.6K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $3.1M across 112 shipments (35.9% of this supplier's total exports)
• TARO PHARMACEUTICALS INC. — $3.0M across 109 shipments (35.0% of this supplier's total exports)
• M/S. SUN FARMACEUTICA DO BRAZIL LTD — $980.0K across 35 shipments (11.3% of this supplier's total exports)
• TARO PHARMACEUTICALS INC. — $790.3K across 28 shipments (9.1% of this supplier's total exports)
• TARO PHARMACEUTICALS INC. — $760.9K across 27 shipments (8.8% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $27.9K is 50% above the market average of $18.6K, consistent with large-order contracts or value-added formulations.
2SUN PHARMACEUTICAL INDUSTRIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD is the second-largest Temozolomide exporter from India, with a market share of 8.4% and a total export value of $2.0M across 19 shipments. Their average shipment value of $103.4K is above the market average of $18.6K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TARO PHARMACEUTICALS INC. — $795.8K across 8 shipments (40.5% of this supplier's total exports)
• SUN FARMACEUTICA DO BRASIL LTD — $763.8K across 7 shipments (38.9% of this supplier's total exports)
• M S TARO PHARMACEUTI — $214.2K across 2 shipments (10.9% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $160.9K across 2 shipments (8.2% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $29.4K across 0 shipments (1.5% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LTD's per-shipment value of $103.4K is 455% above the market average of $18.6K, consistent with large-order contracts or value-added formulations.
3RELIANCE LIFE SCIENCES PRIVATE LIMITED
RELIANCE LIFE SCIENCES PRIVATE LIMITED is the third-largest Temozolomide exporter from India, with a market share of 4.8% and a total export value of $1.1M across 100 shipments. Their average shipment value of $11.3K is below the market average of $18.6K, reflecting a high-volume, competitive pricing strategy.
RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DEM PHARMACEUTICALS — $471.2K across 42 shipments (41.5% of this supplier's total exports)
• JAMP PHARMA CORP — $321.0K across 28 shipments (28.3% of this supplier's total exports)
• DELTA IMPORT - EXPOR — $139.0K across 12 shipments (12.2% of this supplier's total exports)
• JAMP PHARMA CORP — $108.2K across 10 shipments (9.5% of this supplier's total exports)
• DEM PHARMACEUTICALS — $95.3K across 8 shipments (8.4% of this supplier's total exports)
Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED operates with high shipment frequency (100 shipments) at a per-shipment value of $11.3K, indicating a broad distribution network with many smaller, regular orders.
4JODAS EXPOIM PRIVATE LIMITED
JODAS EXPOIM PRIVATE LIMITED is the fourth-largest Temozolomide exporter from India, with a market share of 4.1% and a total export value of $952.5K across 35 shipments. Their average shipment value of $27.2K is above the market average of $18.6K, suggesting premium or bulk contract pricing.
JODAS EXPOIM PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• OOO"JODAS EXPOIM" — $440.9K across 16 shipments (46.3% of this supplier's total exports)
• OOO"JODAS EXPOIM" — $439.3K across 16 shipments (46.1% of this supplier's total exports)
• ZISTA PHARMA LIMITED — $40.8K across 1 shipments (4.3% of this supplier's total exports)
• OOO"JODAS EXPOIM" — $21.7K across 1 shipments (2.3% of this supplier's total exports)
• BANQUE POPULAIRE (BA — $9.9K across 0 shipments (1.0% of this supplier's total exports)
Key Insight: JODAS EXPOIM PRIVATE LIMITED's per-shipment value of $27.2K is 46% above the market average of $18.6K, consistent with large-order contracts or value-added formulations.
5INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the fifth-largest Temozolomide exporter from India, with a market share of 3.0% and a total export value of $699.7K across 49 shipments. Their average shipment value of $14.3K is below the market average of $18.6K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ALLIANCE PHARMA CO., LTD. — $220.7K across 15 shipments (31.5% of this supplier's total exports)
• XXCORXXHEAXXHCAXX PO — $172.8K across 12 shipments (24.7% of this supplier's total exports)
• XXCORXXNL XX XXB — $109.8K across 8 shipments (15.7% of this supplier's total exports)
• EVERSANA LIFE SCIENC — $98.5K across 7 shipments (14.1% of this supplier's total exports)
• XXCORXXHEAXXHCAXX SX — $97.8K across 7 shipments (14.0% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (49 shipments) at a per-shipment value of $14.3K, indicating a broad distribution network with many smaller, regular orders.
6ACCURE LABS PRIVATE LIMITED
ACCURE LABS PRIVATE LIMITED is the fifth-largest Temozolomide exporter from India, with a market share of 2.4% and a total export value of $554.3K across 45 shipments. Their average shipment value of $12.3K is below the market average of $18.6K, reflecting a high-volume, competitive pricing strategy.
ACCURE LABS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• BANQUE POPULAIRE B P — $232.7K across 19 shipments (42.0% of this supplier's total exports)
• NA — $103.7K across 8 shipments (18.7% of this supplier's total exports)
• TO THE ORDER OF — $93.5K across 8 shipments (16.9% of this supplier's total exports)
• BANQUE POPULAIRE B P — $68.6K across 6 shipments (12.4% of this supplier's total exports)
• CREDIT IMMOBILIER ET — $55.8K across 5 shipments (10.1% of this supplier's total exports)
Key Insight: ACCURE LABS PRIVATE LIMITED operates with high shipment frequency (45 shipments) at a per-shipment value of $12.3K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Temozolomide Flows
Once Temozolomide leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LTD, it travels to 5 destination markets with a combined import value of $23.5M. Canada absorbs the largest share at 31.8% ($7.5M), followed by Belgium (22.5%) and Brazil (10.7%).
In Canada — the top destination — named importers include TARO PHARMACEUTICALS INC.,, TARO PHARMACEUTICALS INC, TARO PHARMACEUTICALS INC.. In Belgium, key buyers are YUSEN LOGISTICS BENELUX BELGIUM, YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN.
This geographic spread reflects Temozolomide's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Temozolomide Go? Top Importing Countries & Their Buyers
Trade flow of Temozolomide exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Canada
Canada ranks as the first-largest destination for Temozolomide imports from India, with a total trade value of $7.5M across 38 shipments — representing a 31.8% share of all Temozolomide exports. The average shipment value of $196.5K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Temozolomide importers in Canada: TARO PHARMACEUTICALS INC., is the largest buyer, accounting for 40.7% ($3.0M) of this market's total imports.
• TARO PHARMACEUTICALS INC., — $3.0M (40.7% of Canada's total)
• TARO PHARMACEUTICALS INC — $2.7M (36.1% of Canada's total)
• TARO PHARMACEUTICALS INC. — $760.9K (10.2% of Canada's total)
Key Insight: Canada's per-shipment average of $196.5K (954% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Temozolomide imports from India.
2Belgium
Belgium ranks as the second-largest destination for Temozolomide imports from India, with a total trade value of $5.3M across 207 shipments — representing a 22.5% share of all Temozolomide exports. The average shipment value of $25.6K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Temozolomide importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 88.3% ($4.7M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $4.7M (88.3% of Belgium's total)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $536.7K (10.1% of Belgium's total)
Key Insight: Belgium's per-shipment average of $25.6K (37% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Temozolomide imports from India.
3Brazil
Brazil ranks as the third-largest destination for Temozolomide imports from India, with a total trade value of $2.5M across 7 shipments — representing a 10.7% share of all Temozolomide exports. The average shipment value of $359.1K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Temozolomide importers in Brazil: M/S. SUN FARMACEUTICA DO BRAZIL LTD is the largest buyer, accounting for 39.0% ($980.0K) of this market's total imports.
• M/S. SUN FARMACEUTICA DO BRAZIL LTD — $980.0K (39.0% of Brazil's total)
• SUN FARMACEUTICA DO BRASIL LTD — $763.8K (30.4% of Brazil's total)
Key Insight: Brazil's per-shipment average of $359.1K (1827% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Temozolomide imports from India.
4Russia
Russia ranks as the fourth-largest destination for Temozolomide imports from India, with a total trade value of $1.7M across 13 shipments — representing a 7.1% share of all Temozolomide exports. The average shipment value of $127.8K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Temozolomide importers in Russia: OOO"JODAS EXPOIM" is the largest buyer, accounting for 63.9% ($1.1M) of this market's total imports.
• OOO"JODAS EXPOIM" — $1.1M (63.9% of Russia's total)
• OOOJODAS EXPOIM — $439.3K (26.4% of Russia's total)
Key Insight: Russia's per-shipment average of $127.8K (586% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Temozolomide imports from India.
5United States
United States ranks as the fifth-largest destination for Temozolomide imports from India, with a total trade value of $959.1K across 0 shipments — representing a 4.1% share of all Temozolomide exports. The average shipment value of $959.1K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations.
Key Insight: United States's per-shipment average of $959.1K (5046% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Temozolomide imports from India.
People Also Ask — Temozolomide Supplier & Trade Network
Who are the top suppliers of Temozolomide from India?+
Which companies buy Temozolomide from Indian manufacturers?+
Where does Temozolomide exported from India go?+
What is the market share of the top Temozolomide supplier from India?+
What is the average shipment value for Temozolomide exports from India?+
Is Temozolomide manufactured in India and exported globally?+
Which country imports the most Temozolomide from India?+
Who are the buyers of Temozolomide in Belgium?+
How concentrated is the Temozolomide supplier market in India?+
How do I find verified buyers for Temozolomide in specific countries?+
Temozolomide Trade Network — Key Takeaways
- 1SUN PHARMACEUTICAL INDUSTRIES LIMITED is India's dominant Temozolomide exporter with a 36.9% market share and $8.7M in total exports — making it the single most important sourcing entity in this market.
- 2The top 133 suppliers collectively account for 59.5% of all tracked Temozolomide exports, with a combined trade value of $23.5M.
- 3Canada is the largest destination market, absorbing 31.8% of India's Temozolomide exports ($7.5M). Belgium (22.5%) and Brazil (10.7%) follow.
- 4With 1.3K total shipments averaging $18.6K each, the Temozolomide export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN, TARO PHARMACEUTICALS INC., TARO PHARMACEUTICALS INC., SUN FARMACEUTICA DO BRASIL LTD — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 90 countries
Network value: $23.5M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Temozolomide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Temozolomide.
- 2.Flow Mapping: 133 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,261 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 90 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,261 Verified Shipments
133 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists